Stay updated on Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.6.6' was added to the record history, replacing the previous 'Revision: v3.6.5'. This reflects a minor update to the page's underlying software version rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-08-29T22:00:35.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The record history now shows a new revision entry (v3.6.5) replacing the previous (v3.6.4) to reflect the latest submission. This is a metadata update that does not change the study data or public content.
    Difference
    0.1%
    Check dated 2026-08-08T22:32:12.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry (v3.6.4) as the latest version, and the previous entry (v3.6.3) is removed from the current history view.
    Difference
    0.1%
    Check dated 2026-07-25T12:53:06.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.3, was added to the study record history, replacing the previous v3.6.2. This indicates a routine update to the page's revision tracking or rendering.
    Difference
    0.1%
    Check dated 2026-07-04T03:58:55.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2026-06-27T02:07:19.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.0) was added to the study history, introducing the verifier’s name (wang shusen) and updated last-verified metadata. The change strengthens the audit trail by clarifying who verified the record and which version is current.
    Difference
    3%
    Check dated 2026-06-12T16:12:46.000Z thumbnail image

Stay in the know with updates to Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page.